{"entity":{"entity_id":"2dc9492b-8afa-424a-a63e-3c4cc18bafa8","entity_url":"https://factanker.com/entity/2dc9492b-8afa-424a-a63e-3c4cc18bafa8","label":"REGENERON PHARMACEUTICALS, INC.","type":"org","anchors":{"cik":"0000872589","qid":"Q7308054"}},"answer":"In fiscal year 2025, US federal obligations equal -2.3% of REGENERON PHARMACEUTICALS, INC.'s reported revenue - $-331.7M in federal awards against $14.3B in revenue as filed with the SEC.","cite_as":"FACTANKER, https://factanker.com/entity/2dc9492b-8afa-424a-a63e-3c4cc18bafa8/government-dependency","method":"EDGAR revenue (company fiscal year) against USAspending obligations (federal fiscal year of the award date); identity via evidence-backed same_as facts.","series":[{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2026,"revenue_usd":null,"obligations_usd":4694089.24,"awards":4,"gov_share":null,"data_completeness":"complete"},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2025,"revenue_usd":14342900000.0,"obligations_usd":-331708160.1,"awards":4,"gov_share":-0.0231,"data_completeness":"complete"},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2024,"revenue_usd":14202000000.0,"obligations_usd":-1435528.0,"awards":5,"gov_share":-0.0001,"data_completeness":"complete"},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2023,"revenue_usd":13117200000.0,"obligations_usd":326475498.0,"awards":5,"gov_share":0.0249,"data_completeness":"complete"},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2022,"revenue_usd":12172900000.0,"obligations_usd":494095.2,"awards":7,"gov_share":0.0,"data_completeness":"complete"},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2021,"revenue_usd":16071700000.0,"obligations_usd":5565148228.56,"awards":9,"gov_share":0.3463,"data_completeness":"contracts_only"},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2020,"revenue_usd":8497100000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2019,"revenue_usd":6557600000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2018,"revenue_usd":5145600000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2017,"revenue_usd":5872200000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2016,"revenue_usd":4860400000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2015,"revenue_usd":2689478000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2014,"revenue_usd":1750762000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2013,"revenue_usd":1425839000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2012,"revenue_usd":858093000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2011,"revenue_usd":445824000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2010,"revenue_usd":459074000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2009,"revenue_usd":379268000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"REGENERON PHARMACEUTICALS, INC.","cik":"0000872589","lei":"549300RCBFWIRX3HYQ56","qid":"Q7308054","uei":"N3F9MH7E6HD6","ein":null,"fiscal_year":2008,"revenue_usd":238457000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null}],"not_claimed":["Obligations are federal fiscal years (Oct–Sep), revenue is the company's fiscal year — the periods do not align exactly.","For years with data_completeness='contracts_only' only contracts are loaded, assistance is still missing — for grant recipients the total is therefore too low."],"retrieved_at":"2026-10-24T05:19:11"}